Chemoinformaics analysis of 3-Nitrofluoranthene
| Molecular Weight | 247.253 | nRot | 1 |
| Heavy Atom Molecular Weight | 238.181 | nRig | 20 |
| Exact Molecular Weight | 247.063 | nRing | 4 |
| Solubility: LogS | -7.205 | nHRing | 0 |
| Solubility: LogP | 4.76 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 3 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 17 |
| nHA | 2 | APOL | 35.4251 |
| nHD | 0 | BPOL | 10.1949 |
| QED | 0.369 |
| Synth | 1.943 |
| Natural Product Likeliness | -0.728 |
| NR-PPAR-gamma | 0.981 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.009 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.62 |
| MDCK | 0.000122185 |
| BBB | 0.249 |
| PPB | 0.988463 |
| VDSS | 0.624 |
| FU | 0.00670345 |
| CYP1A2-inh | 0.978 |
| CYP1A2-sub | 0.188 |
| CYP2c19-inh | 0.76 |
| CYP2c19-sub | 0.065 |
| CYP2c9-inh | 0.684 |
| CYP2c9-sub | 0.931 |
| CYP2d6-inh | 0.284 |
| CYP2d6-sub | 0.914 |
| CYP3a4-inh | 0.428 |
| CYP3a4-sub | 0.143 |
| CL | 2.685 |
| T12 | 0.056 |
| hERG | 0.371 |
| Ames | 0.984 |
| ROA | 0.052 |
| SkinSen | 0.952 |
| Carcinogencity | 0.835 |
| EI | 0.991 |
| Respiratory | 0.855 |
| NR-Aromatase | 0.467 |
| Antiviral | Yes |
| Prediction | 0.663473 |